Subsequent Events (Detail Textuals) - Subsequent Event - USD ($) |
1 Months Ended | ||
---|---|---|---|
Feb. 28, 2019 |
Feb. 01, 2019 |
Jan. 31, 2019 |
|
Pharmaceuticals International, Inc. Agreement | |||
Subsequent Event [Line Items] | |||
Estimated initial payment for contract | $ 72,500 | ||
RRD International Agreement | |||
Subsequent Event [Line Items] | |||
Amount of payments due under the contract | 78,680 | ||
Amount of pass through expenses and consulting fees | $ 22,000 | ||
2nd Draw on Multi Draw Credit Facility | |||
Subsequent Event [Line Items] | |||
Value of warrants issued | $ 2,000,000 | ||
Number of warrants issued | 2,500,000 | ||
Warrant exercise price | $ 0.50 | ||
Noramco Agreement | |||
Subsequent Event [Line Items] | |||
Upfront payment | $ 146,386 |
X | ||||||||||
- Definition Represent the amount of pass through expenses and consulting fees. No definition available.
|
X | ||||||||||
- Definition Estimated Initial Payment For Contract. No definition available.
|
X | ||||||||||
- Definition It represents as a total advances under multi-draw credit facility. No definition available.
|
X | ||||||||||
- Definition This element represents amount of upfront payment. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|